AGA Medical Debuts During Cautious IPO Market (AGAM)
It was just over the weekend that we noted how cautious the initial public offering market has become. What a difference a couple months can make. Today marks the debut of AGA Medical Holdings, Inc. (NASDAQ: AGAM). The medical devices…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The problem with this offering is that this was priced below the revised $15 to $16 per share range, which had already been reduced from a previous range of $19 to $21 per share. BofA Merrill Lynch, Citi, Deutsche Bank Securities, Leerink Swann and Wells Fargo were listed as the joint book-running managers for the IPO. These underwriters have a 30-day option to purchase up to an additional 2,062,500 shares of common stock to cover over-allotments.
For the year ended December 31, 2008 and the six months ended June 30, 2009, respectively, AGA Medical generated revenues of $166.9 million and $94.4 million; and it generated EBITDA of $46.5 million and $17.8 million and net income of $9.1 million in 2008 and a loss of -$4.2 million during the first six-months this year.
AGA Medical is a private equity-backed investment, with Welsh Carson, Anderson, & Stowe and affiliates of the firm. The backers are selling shares, but will still hold a majority if the over-allotment is not taken and will hold about 49.6% of AGA Medical if the over-allotment is taken.
At 11:00 AM EST we have seen some 2.6 million shares trade hands and the stock is up at $14.52 after having seen a post-open trading range of $14.32 to $14.85.
JON C. OGG
OCTOBER 21, 2009
Contact [email protected] for any questions or corrections.